XML 40 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION
We issue restricted stock units (“RSUs”), which consist of time-based and performance-based awards, to employees under stock awards plans approved by stockholders. In addition, RSUs are issued to non-employee directors under a Restricted Stock Unit Award Agreement for Directors pursuant to the Company's 2018 Equity Incentive Plan. RSUs granted to employees vest according to a specified performance period and/or vesting period. Time-based RSUs generally vest over three years. Performance-based RSUs vest at the end of the specified performance period, generally three years, assuming required performance or market vesting conditions are met.
For awards granted in the first quarter of 2023, our performance-based RSUs will vest solely based on our return of invested capital ("ROIC"). Award share payouts depend on the extent to which the ROIC performance goal has been achieved, but the final payout is adjusted by a total shareholder return (“TSR”) modifier.
At the time of vesting, the vested shares of common stock are issued in the employee’s name. RSUs granted to directors are only time-based and generally vest over one year.
The fair value of both time-based RSUs and performance-based RSUs pertaining to internal performance metrics is determined using the closing price of our common stock on the grant date. The fair value of performance-based RSUs pertaining to TSR is estimated using a Monte Carlo simulation. Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement.
Year Ended December 31,2023(1)20222021
Fair value per stock award$116.17 $141.95 $171.63 
Grant date stock price$111.38 $114.52 $141.59 
Assumptions:
Aptar's stock price expected volatility20.00 %20.20 %21.40 %
Expected average volatility of peer companies39.70 %41.70 %50.00 %
Correlation assumption33.30 %41.20 %58.10 %
Risk-free interest rate3.83 %2.04 %0.32 %
Dividend yield assumption1.36 %1.33 %1.02 %
(1)The 2023 award inputs and assumptions are related to PSU-ROIC awards with a TSR modifier.
A summary of RSU activity as of December 31, 2023, and changes during the period then ended is presented below:
Time-Based RSUsPerformance-Based RSUs
UnitsWeighted Average
Grant-Date Fair Value
UnitsWeighted Average
Grant-Date Fair Value
Nonvested at January 1, 2023
426,361$111.60 610,871$118.77 
Granted123,657110.55 151,499115.69 
Vested(193,820)105.00 (99,182)89.33 
Forfeited(20,324)111.17 (148,805)96.24 
Nonvested at December 31, 2023335,874$115.15 514,383$130.10 
Included in the December 31, 2023 time-based RSUs are 11,508 units granted to non-employee directors and 10,589 units vested related to non-employee directors.
Year Ended December 31,202320222021
Compensation expense$37,015 $40,937 $38,643 
Fair value of units vested29,100 32,013 32,414 
Intrinsic value of units vested33,914 33,024 42,970 
The actual tax benefit realized for the tax deduction from RSUs was approximately $5.9 million, $8.0 million and $7.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. As of December 31, 2023, there was $41.1 million of total unrecognized compensation cost relating to RSU awards which is expected to be recognized over a weighted average period of 1.7 years.
Historically we issued stock options to our employees and non-employee directors. We did not issue stock options between 2019 and 2022. Stock options were awarded in the first quarter of 2023 with the exercise price equal to the market price on the date of grant; however, Aptar executive officers received stock options with an exercise price that was 110% of the closing market price on the date of grant. Stock option grants generally vest ratably over three years and expire 10 years after grant.
The Company uses historical data to estimate expected life and volatility. The weighted-average fair value of stock options granted under the stock awards plans were $19.84 and $24.23 per share for executive officers and all others employees, respectively, during 2023. These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Stock Award Plans:
Year Ended December 31,2023
Dividend Yield1.41 %
Expected Stock Price Volatility16.55 %
Risk-free Interest Rate3.57 %
Expected Life of Option (years)7.0
A summary of option activity under our stock plans as of December 31, 2023, and changes during the period then ended is presented below:
Stock Awards PlansDirector Stock Option Plans
OptionsWeighted Average
Exercise Price
OptionsWeighted Average
Exercise Price
Outstanding, January 1, 2023
2,623,944 $73.34 51,700 $63.91 
Granted315,005 116.19   
Exercised(749,899)69.94 (32,700)62.36 
Forfeited or expired(6,266)93.23   
Outstanding at December 31, 20232,182,784 $80.63 19,000 $66.59 
Exercisable at December 31, 20231,871,178 $74.70 19,000 $66.59 
Weighted-Average Remaining Contractual Term (Years):
Outstanding at December 31, 20233.50.4
Exercisable at December 31, 20232.60.4
Aggregate Intrinsic Value:
Outstanding at December 31, 2023$93,830 $1,084 
Exercisable at December 31, 2023$91,533 $1,084 
Intrinsic Value of Options Exercised During the Years Ended:
December 31, 2023$38,706 $1,978 
December 31, 2022$20,608 $— 
December 31, 2021$69,862 $4,248 
Year Ended December 31,202320222021
Compensation expense (included in SG&A)$3,929 $— $185 
Compensation expense (included in Cost of sales)349 — 42 
Compensation expense, Total$4,278 $— $227 
Compensation expense, net of tax4,278 — 174 
Grant date fair value of options vested2,663 — 2,421 
The increase in stock option expense is due to the newly issued options as discussed above. Cash received from option exercises was approximately $54.0 million, $28.5 million and $59.9 million for the years ended December 31, 2023, 2022 and 2021, respectively. The actual tax benefit realized for the tax deduction from option exercises was approximately $9.1 million, $4.4 million and $16.5 million in the years ended December 31, 2023, 2022 and 2021, respectively. As of December 31, 2023, there was $2.7 million of total unrecognized compensation cost relating to stock option awards which is expected to be recognized over a weighted-average period of 2.0 years.